PWAM
SONM icon

Park West Asset Management’s DNA X Inc SONM Stock Holding History

Park West Asset Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-56
Closed -$293K – 83
2019
Q3 		$293K Hold
56
– – 0.01% 74
2019
Q2 		$1.27M Buy
+56
New +$1.42M 0.05% 77

Other funds holding SONM

NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
PC
PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return

Park West Asset Management's SONM Position: Q4 2019 in Review

Park West Asset Management sold out of DNA X Inc (SONM) in Q4 2019, closing a stake of 56 shares — an estimated $293K sold.

Park West Asset Management first reported a position in SONM in Q2 2019 and held it in 2 quarters. The position peaked at $1.27M in Q2 2019. 40 funds tracked by Wall St. Rank hold SONM as of Q4 2019.

  • Park West Asset Management reported no remaining DNA X Inc position as of Q4 2019 after selling out during the quarter.
  • Park West Asset Management sold 56 DNA X Inc shares in Q4 2019, an estimated $293K.
  • Park West Asset Management first reported a position in DNA X Inc in Q2 2019 and held it in 2 quarters.
  • Park West Asset Management's DNA X Inc position peaked at $1.27M in Q2 2019.
  • 40 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2019.

Based on Park West Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.